Skip to main content

Table 2 Clinical characteristics of the sample (n = 92)

From: Validity and reliability of the Portuguese version of the modified Migraine Disability Assessment

Variable Value N %
Age of migraine diagnosis (years) Min-max 2–76  
Mean ± standard deviation 31.2 ± 14.7  
<  20 27 29.3
21–39 39 42.4
≥ 40 26 28.3
Time on consultation (years) Min-max 0–37  
Mean ± standard deviation 3.8 ± 5.6  
<  1 36 39.2
1–3 27 29.3
≥ 4 29 31.5
Frequency of headaches in previous month Min-max 0–30  
Mean ± standard deviation 8.9 ± 4.5  
Prophylactic treatment Now, continued 41 49.4
Now, not previously 17 20.5
Not now, but previously yes 18 21.7
Never 7 8.4
Previous prophylactic treatment Yes 59 71.1
No 24 28.9
Drugs prescribed Antiepileptic 50 54.3
Antidepressant 48 52.2
Beta-Blockers 34 36.9
Botulinum Toxin A 1 12.0
Calcium Blockers 7 7.6
Non-Steroidal anti-Inflammatory 4 1.4
Neuromodulation Devices 1 1.1
Invasive Treatments 1 1.1
Other 10 10.9
Acute treatment for migraine Yes 89 97.8
No 2 2.2
Acute therapeutics usually followed Analgesics 84 91.3
Trypanoes 44 47.8
Antiemetics 15 16.3
Opioids 6 6.5
Ergotaminicos 5 5.4
Corticosteroids 2 2.2
Other 1 1.1
Other comorbidities Yes 18 20.9
No 68 79.1